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Objective: to validate the content of the prevention protocol for early sepsis caused by 
Streptococcus agalactiae in newborns. Method: a transversal, descriptive and methodological 
study, with a quantitative approach. The sample was composed of 15 judges, 8 obstetricians and 
7 pediatricians. The validation occurred through the assessment of the content of the protocol 
by the judges that received the instrument for data collection – checklist – which contained 
7 items that represent the requisites to be met by the protocol. The validation of the content 
was achieved by applying the Content Validity Index. Result: in the judging process, all the 
items that represented requirements considered by the protocol obtained concordance within the 
established level (Content Validity Index > 0.75). Of 7 items, 6 have obtained full concordance 
(Content Validity Index 1.0) and the feasibility item obtained a Content Validity Index of 0.93. 
The global assessment of the instruments obtained a Content Validity Index of 0.99. Conclusion: 
the validation of content that was done was an efficient tool for the adjustment of the protocol, 
according to the judgment of experienced professionals, which demonstrates the importance of 
conducting a previous validation of the instruments. It is expected that this study will serve as an 
incentive for the adoption of universal tracking by other institutions through validated protocols.
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Introduction
The neonatal infection by the B group β-hemolytic 
Streptococcus (EGB), or Streptococcus agalactiae, is 
considered an important problem of public health, being 
the main cause of early neonatal sepsis, the generalized 
infection that occurs on the first 48 hours of life, having 
a direct relationship with the gestational or intra-partum 
period, according to the definition by the Brazilian 
Ministry of Health. The sepsis represents one of the most 
important causes of neonatal morbidity and mortality, 
and its incidence varies from one to eight cases for every 
thousand born alive. In Brazil, the rate of mortality is 
around 25%. International databases demonstrate that 
around 30 million of newborns are diagnosed with sepsis 
and from one to two million of them die. 
Among other complications due to the infection by 
the Streptococcus agalactiae in newborns some of them 
need to be emphasized: meningitis, pneumonia, septic 
abortion, chorioamnionitis, endometritis, increase in 
mortality and morbidity, neurological deficit, long-term 
hospital confinement and neonatal decease. Vertical 
transmission is the most common and its determining 
factor is the exposure of the newborn to the EGB that 
are present in the vagina, which is colonized in the 
intra-partum period5. Among the newborns of mothers 
that possess the EGB, the colonization occurs in 50% 
of the cases. Considering the prevalence of the national 
maternal colonization in 20%, there will be incidence 
of two cases for every thousand born, provided the 
absence of prophylactic interventions. 
With the understanding of the relevance of this 
issue in the context of public health, in the late 1990’s, a 
process of implementation of prophylactic interventions 
started, intending to control the EGB infection in 
newborns, which were improved through time. In 
1996, the Center for Diseases Control and Prevention 
(CDC) published in the USA the first national consensus 
directives about perinatal prevention of infections 
caused by Streptococcus agalactiae. Two prophylactic 
strategies for the intra-partum period were established. 
The first was based on the risk factors and the second in 
the results of the tracking on the genitorectal secretion 
cultures, collected between the 35th and the 37th week of 
pregnancy, for the EGB research.
In August 2002, based on the new evidences of 
a retrospective study, these directives were updated, 
being now recommended the universal tracking through 
genitorectal culture between the 35th and the 37th week 
of gestation as the only strategy for the orientation of the 
intra-partum chemoprophylaxis of the early infection by 
the EGB. This approach consists in doing a microbiological 
examination, with the goal of limiting, in terms of candidacy 
to the intra-partum prophylaxis, just the patients colonized 
by the EGB, regardless of the risk factors. This study 
demonstrated that the effectiveness of the late antenatal 
tracking, through the EGB culture, was 50% superior to 
the alternate approach based on the risk factors.
In 2010, the 3rd review of the directives based on 
the updated evidences of perinatal prevention for the 
EGB was published. The CDC 2010 version highlights the 
indications for universal “screening” on the 3rd trimester 
of the gestation, standardizing the laboratory methods 
about the collection and transportation of samples for 
the detection of the GBS, taking into consideration 
the changes in the arrangement and of the indication 
of the antimicrobials recommended for the intra-
partum prophylaxis and by supplying updates for the 
recommendations for newborns at risk to have an early 
infection.
The change of conduct in the USA, through the 
implementation of the orientations established by the 
CDC, suggests a decline in the incidence of the early 
disease caused by the EGB in the country, provided that, 
among newborns with up to 6 days of life, the incidence 
of the B group streptococcus disease was reduced from 
0.47 of  a thousand successful births, between 1999 and 
2001, to 0.34 of a thousand successful births, between 
2003 and 2005, which corresponds to a reduction of 
27% after the implementation of the CDC 2002 guide. 
Other data evinced that in the USA there was a reduction 
equivalent to 1.2% in the annual rate of hospitalization 
among the pre-term newborns, between 1988 and 
2006, and that can be a consequence of the results of 
the implementation of the preventive measures.
The Hospital das Clínicas of the Federal University 
of Pernambuco (HC/UFPE) did not have the protocol for 
the prevention of the neonatal infection by the EGB. This 
way, the genitorectal culture is not done frequently, which 
makes it impossible to know the state of the maternal 
colonization. Given that, the prevention of the perinatal 
infection by EGB is done through the administration 
of the intra-partum antibiotic in pregnant women that 
present risk factors on neonatal transmission, such 
as the long period necessary for the rupture of the 
amniotic membrane and the premature labor. However, 
this approach presents a limited efficiency and such 
indiscriminate use of antibiotics, in all pregnant women 
with risk factors, may contribute for the emergence of 
new and more resistant strains.
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Given the available evidences about the relevance 
of the infection within public health policies, the 
consequences for the concept and the precision of 
the intra-partum prophylaxis based on the universal 
tracking, it was developed a protocol for the 
prevention of the neonatal sepsis by the EGB, based 
on the recommendations of the CDC 2010 guide, to be 
implemented in the pre-natal, obstetrics and neonatal 
units of the HC/UFPE.
Taken into consideration the importance of the 
adequacy of the protocol regarding the semantic and 
content aspects, the validation of the content by judges 
emerge as a tool to meet this requirement, because it 
allows professionals that are experienced in this area to 
provide significant collaborations to the protocol.
Provided what was mentioned previously, this study 
had the goal of validating the content of the prevention 
protocol of the early sepsis caused by the Streptococcus 
agalactiae in newborns.
Method
This is a transversal, descriptive and methodological 
study with a quantitative approach, conducted at the 
HC/UFPE, an institution specialized in the care of high-
risk pregnancies, between May and August 2013.
The population was made of obstetricians and 
pediatricians from the Obstetrics Center at the HC/UFPE, 
with a minimum experience of four years in pediatrics 
or obstetrics. The sample, by willfulness, included 10 
obstetricians and 10 pediatricians. These were included due 
to a 4 year minimum experience in neonatology at the HC/
UFPE. The adopted criteria for exclusion were the following: 
failure to deliver the questionnaire within the established 
deadline or the inadequate filling of the questionnaires. 
The validation by the judges occurred through 
the evaluation of the content of the protocol for the 
prevention of neonatal sepsis caused by EGB, based 
on the CDC 2010 guide. Through this, the contact 
was established in order to invite pediatricians and 
obstetricians to participate in the research. For all those 
that accepted participating, the protocol that was made 
to meet the requirements of the study was delivered, as 
well as a letter containing the objectives of the study, the 
justification of the process of the assessment protocol 
and the instrument for the data collection, a checklist 
containing seven items that represent the requisites to 
be met by the protocol.
The evaluation of the instrument occurred from the 
classification of every item in terms of being adequate, 
partially adequate or inadequate. The ones considered 
adequate were those that completely met the 
established requirement; partially adequate were those 
that required some changes; and inadequate were those 
that expressed a complete non-compliance in relation to 
the established criteria.
The judges were instructed to give the material back 
after the analysis and to give their final opinion personally 
to the researchers, within the 30 day deadline. For the 
cases in which were considered to have inadequacies, 
the reasons were explained, the suggestions described 
and the contents rewritten, improved and submitted 
to a new assessment. To the judges were also granted 
explanations, when they were requested, related to the 
practices established in the protocol.
The variables that were analyzed were: 
vocabulary, relevance, clinical-scientific aspects, 
clarity, feasibility, organization and scope. After the 
assessment of the protocol, the validation of the 
content was done, with the application of the Content 
Validity Index (CVI) that measures the proportion or 
percentage of the judges that express agreement in 
relation to the instrument’s items.
The specialized literature presents different 
possibilities for the calculation of the CVI, as well as for 
the establishment of its minimum level of concordance. 
It is possible to calculate the score of this Index by 
adding up the items that were deemed relevant. In 
the case of this study, it was considered an adequate 
judgment by all judges. The CVI calculation for the 
instrument, as a whole, was done through the addition 
of all the CVIs, calculated separately, divided by the 
number of items of the instruments. It was considered 
the minimum concordance index for the CVI the number 
0.75, by consensus, both for the assessment of every 
item and the instrument general assessment.
The data collected were electronically processed, 
with the aid of the Excel 20 program. For the analysis 
the manual calculation of the CVI was applied, as it 
was previously described and percentages for the 
characterization of the sample were utilized.
All the judges were informed about the goals of 
the research, being included only the participants that 
signed the Informed Consent Form. The ethical aspects 
were observed, with respect to the Resolution 466/2012 
of the Brazilian National Health Council (CNS). The data 
collection started after the approval of the project by 
the Research Ethics Committee of the Center of Health 
Sciences at the Federal University of Pernambuco 
(ruling 487.861).
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Results
Initially, the sample included 20 judges. However, 
there were 5 exclusions: 2 for refusal in participating in 
all phases, 1 for inadequate filling of the form, 1 for not 
returning the material and 1 that abandoned. This way, 
the sample was made up by 15 judges, 8 obstetricians 
and 7 pediatricians. Table 1 shows the characterization 
of the judges.
Table 1 – Data related to the identification of the judges, 
according to gender, experience and titration. Recife, PE, 
Brazil, 2013.
Variables n %
Gender
Feminine 9 60.0
Masculine 6 40.0
Titration
Specialization 8 53.3
Master’s Degree 5 33.3
PhD 2 13.3
Experience
6 to 10 years 1 6.5
>10 years 14 93.5
Total 15 100.0
It can be observed in Table 1 that among the 
participants there was the prevalence of the feminine 
gender (9 = 60%). The experience years varied from 10 to 
38 years, and 14 (93.5%) of the judges had an experience 
time greater than 10 years. Regarding the titration, 5 
(33.3%) had a Master’s degree and 2 (13.3%) had a PhD.
As it was demonstrated in Table 2, in the process 
of judging the requisites related to the protocol of 
prevention of the neonatal sepsis caused by EGB, after 
the first assessment which was done by the judges no 
item was deemed as inadequate. However, only the 
item relevance had total approval (CVI 1.0) and the 
others required changes. It was observed that the items 
vocabulary, clarity and feasibility had a CVI below the 
established level (CVI < 0.75).
When the protocol was submitted for a new 
analysis after its correction, considering the suggestions 
of the judges, all the items obtained concordance 
within the established level (CVI > 0.75). Of the 7 
items, 6 obtained full concordance (CVI = 1.0) and 
the item Feasibility obtained a CVI of 0.93. The global 
assessment of the instruments had a CVI of 0.99, 
demonstrating concordance within the established 
level (Table 3).
Table 2 – First step of judgment made by the judges about the items of the protocol of prevention of the early 
infection by the Streptococcus agalactiae in a newborn. Recife, PE, Brazil, 2013.
Items
Judgment
CVI*Adequate with alterations Adequate
N % N %
Vocabulary 4 26.5 11 73.5 0.73
Relevance - - 15 100 1.0
Clínical-Scientific Aspects 2 13.5 13 86.5 0.86
Clarity 5 33.5 10 66.5 0.66
Feasibility 5 33.5 10 66.5 0.66
Organization 2 13.5 13 86.5 0.86
Scope 1 6.5 14 93.5 0.93
* Content Validity Index (CVI)
Table 3 – Second step of the judgment of the items of the protocol of prevention of the early infection by Streptococcus 
agalactiae in newborns. Recife, PE, Brazil, 2013.
Items
Judgment
CVI*Adequate with alterations Adequate
n % N %
Vocabulary - - 15 100 1.0
Relevance - - 15 100 1.0
Clinical-Scentific Aspects - - 15 100 1.0
Clarity - - 15 100 1.0
Feasibility 1 6.5 14 93.5 0.93
Organization - - 15 100 1.0
Scope - - 15 100 1.0
* Content Validity Index (CVI)
639
www.eerp.usp.br/rlae
Silva FA, Vidal CFL, Araújo EC.
The most important questionings highlighted by 
the judges considered to be necessary for adjustments 
were related to the structure of the flowcharts, the 
adequacy of the vocabulary, the lack of description of the 
evidence levels, repeated information, the need for the 
elaboration of sentences more clearly and the inclusion 
of the diagram in the description of the prenatal conduct. 
For other questionings, clarifications were provided by 
personal contact established with the judge.
Discussion
Considering the titration of the judges and the 
minimum experience time of 10 years in almost all 
cases, adding that the HC/UFPE is a hospital-school 
in which the activities are together with the learning, 
research and extension inseparably, it is possible to 
state that it is an experienced group and it is inserted 
in a context that provides the opportunity for constant 
updating, suggesting that the judges possess the 
desirable qualification for the judgment of the protocol.
The obstetrics nurses are qualified to provide 
care for low-risk pregnancies during the prenatal 
period, for normal childbirth without dystocia and in 
the puerperium, in health facilities or at home. In case 
there is any complication during pregnancy that may 
characterize a high-risk pregnancy, these professionals 
should refer the pregnant woman to the doctor, so that 
he or she can continue to provide assistance. Keeping 
in mind that HC/UFPE is an institution specialized in the 
care of high-risk pregnancies, in which the care to these 
patients in the Prenatal and at the Obstetrics Center is 
given by the doctor – the sample did not include nurses.
The low-risk prenatal is done by the professionals 
that belong to the Program for the Family’s Health 
(PSF), which is present in 92% of Brazilian cities. Given 
that, the doctors and nurses that act within the PSF 
need to pay attention to the importance of doing the 
microbiological exam for the detection of the B group 
β-hemolitic Streptococcus. The challenge consists in, up 
to the present moment, the limited availability in the 
labs entailed to the Brazilian Sistema Único de Saúde 
(Unified Health System) for the prenatal routine, which 
suggests the need for stimulating the professionals to 
the introduction of the classification of the Streptococcus 
agalactiae between the 35th and the 37th weeks in the 
assessment of the pregnant women, in their respective 
local health facility.
Regarding the judgment process, it can be 
observed that the item Relevance obtained consensual 
total approval, which highlights the importance of doing 
the swab in the pregnant women for the research of 
the B group β-hemolitic Streptococcus, as a way to 
orientate the prophylaxis and the treatment directed to 
the reduction of the prevalence of the neonatal infection 
by the group B Streptococcus are limited, provided 
that the recommendation for the universal tracking for 
the EGB research in all pregnant women between the 
35th and the 37th weeks is not present in the manuals 
written by the Ministry of Health, which is restricted to 
special situations, such as: premature rupture of the 
membrane, premature labor and pregnant women that 
are HIV-positive.
The justification is based on a systematic review, 
that assessed the use of the intra-partum prophylactic 
antibiotic and the maternal and neonatal outcomes, 
making clear that, although there is a decrease in the 
occurrence of the infection caused by the EGB (RR 
0.17, CI 95%, 0.04 to 0.74), there is a possibility that 
the results were influenced by the authors, due to a 
methodological flaw of the studies. The authors add that 
currently there are no satisfactory evidences to state 
that the intra-partum antibiotic prophylaxis is related 
to the reduction of the neonatal mortality due to this 
disease.
As the recognition of these controversies, related to 
the viability and the impact of the orientations published 
by the CDC, has a result in the lack of standardization 
of the preventive strategies in many countries and the 
uncertainty about the efficiency of these practices, 
recently a systematic review with meta-analysis, 
through an electronic query at the Cochrane Library, that 
had the goal of determining the best tracking strategy 
for the EGB in pregnant women. The results of this 
study demonstrated that the adoption of the universal 
tracking and of the antibiotic prophylaxis resulted in 
an important reduction in the incidence of the neonatal 
sepsis, making clear that the adoption of the universal 
tracking for pregnant women, added to the antibiotic 
prophylaxis, are efficient measures.
As the importance of this theme is considered in 
the context of Public Health, the City Department of 
Health of São Paulo published a technical note based on 
the CDC 2002 guide, for the tracking and prophylaxis 
of the EGB among the pregnant women registered in 
the Mãe Paulistana Program. Statistical data referring 
to the acquired infections in the perinatal period in the 
city of São Paulo demonstrate that there was a reduction 
from 57.8%, in 2000, to 55.1% in 2008, and that can be 
related to the impact of the actions of the public policies 
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regarding the care to the neonatal infection caused by 
the EGB.
It is of great importance that the tracking for the 
research of the EGB in all pregnant women between 
the 35th and the 37th weeks is included in the Ministry 
of Health’s manuals, given that the indiscriminate use 
of antibiotics may entail an increase in the resistant 
strains. Furthermore, it is known that policies based on 
prevention result in a cost-effectiveness relation that is 
superior to the healing model.
At the HC/UFPE, the prophylaxis is based in the 
administration of crystalline penicillin in pregnant women 
that present risk factors. However, the impossibility 
of identifying the state of the maternal colonization 
can be interpreted as a risk for the transmission of 
the infection. This fact was demonstrated in the study 
conducted in pregnant women that have undergone 
intra-partum prophylaxis for the prevention of the 
maternal transmission of the EGB infection, based on 
risk factors in a maternity hospital in Minas Gerais, 
Brazil. The results revealed that 71.2% of the patients 
that received intra-partum prophylaxis according to 
their risk factors were not colonized by the EGB. On the 
other hand, 33.3% of the patients that did not receive 
the intra-partum prophylaxis were colonized. While the 
first piece of information may indicate that the clinical 
judgment led to the unnecessary use of antibiotics in 
around 7 out of 10 pregnant women, the second one 
indicates that the clinical judgment has flaws, provided 
that the colonized patients, that do not present risk 
factors, will not benefit from the prophylaxis.
The penicillin remains as the antibiotic of choice 
for the intra-partum prophylaxis, given that the EGB 
presents a considerable sensibility. On the other hand, 
a study done in a maternity hospital in Ceará, Brazil, 
demonstrated a high resistance in 4 out of 9 cases 
of pregnant women colonized by the Streptococcus 
agalactiae. This finding may be justified by the 
identification of molecular forms of these bacteria that 
present mutations in the gene of the protein of penicillin 
bonding, resulting in the reduction of the susceptibility 
to this medicine. Given that, the promotion of the 
rational use of the antibiotics becomes important, which 
was made possible through the development of the 
protocols. In the present study the protocol that was 
developed limited the chemo-prophylaxis, provided 
that in the pregnant women with a positive result for 
the culture this should only be indicated for the women 
colonized by the EGB or in the presence of asymptomatic 
bacteriuria, intra-partum fever, or a history of newborns 
stricken by the infection by the Streptococcus agalactiae 
in previous births.
It is worth highlighting that this study presented a 
limitation, provided that the validity of the content is a 
subjective process, being necessary a future validation 
through additional clinical application. This fact remits to 
the need for the conduction of future researches, with 
the intent of verifying the results of the application of 
the protocol in the neonatology and obstetrics sectors 
of the HC/UFPE.
Conclusion
The validation of the content done in this study 
was an effective tool to assess the adequacy of the 
protocol, in agreement with the judgment emitted by 
professionals with a wide experience in their area. 
According to the results that were obtained, after 
pondering the suggestions proposed by the judges, the 
content of the protocol for the prevention of the early 
neonatal sepsis by the Streptococcus agalactiae can be 
considered satisfactory and adequate, demonstrating 
the importance of doing a previous validation of the 
instruments. This first step represents an important 
phase in the validation process; however, the need for 
the production of studies should be highlighted, with the 
intention of submitting them to clinical applications.
Bearing in mind the serious consequences of the 
early perinatal streptococcal disease, in opposition to 
the methods of tracking of the B-group Streptococcus in 
the prenatal period, it is expected that this study works 
as an incentive to the adoption of the universal tracking 
by other institutions, both in the public and private 
healthcare systems, through validated protocols, based 
on the scientific knowledge that comes from researches 
based on the prevalence, prophylaxis and therapeutics 
of this relevant perinatal pathology.
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